Daniels Geoff, Ballif Bryan A, Helias Virginie, Saison Carole, Grimsley Shane, Mannessier Lucienne, Hustinx Hein, Lee Edmond, Cartron Jean-Pierre, Peyrard Thierry, Arnaud Lionel
International Blood Group Reference Laboratory, National Health Service Blood and Transplant, Bristol, United Kingdom;
Department of Biology, University of Vermont, Burlington, VT;
Blood. 2015 Jun 4;125(23):3651-4. doi: 10.1182/blood-2015-03-631598. Epub 2015 Apr 20.
The Augustine-negative alias At(a-) blood type, which seems to be restricted to people of African ancestry, was identified half a century ago but remains one of the last blood types with no known genetic basis. Here we report that a nonsynonymous single nucleotide polymorphism in SLC29A1 (rs45458701) is responsible for the At(a-) blood type. The resulting p.Glu391Lys variation in the last extracellular loop of the equilibrative nucleoside transporter 1 (ENT1; also called SLC29a1) is known not to alter its ability to transport nucleosides and nucleoside analog drugs. Furthermore, we identified 3 individuals of European ancestry who are homozygous for a null mutation in SLC29A1 (c.589+1G>C) and thus have the Augustine-null blood type. These individuals lacking ENT1 exhibit periarticular and ectopic mineralization, which confirms an important role for ENT1/SLC29A1 in human bone homeostasis as recently suggested by the skeletal phenotype of aging Slc29a1(-/-) mice. Our results establish Augustine as a new blood group system and place SLC29A1 as a new candidate gene for idiopathic disorders characterized with ectopic calcification/mineralization.
奥古斯汀阴性别名阿特(a-)血型似乎仅限于非洲裔人群,半个世纪前就已被发现,但仍是最后一种尚不知其遗传基础的血型之一。在此,我们报告SLC29A1基因中的一个非同义单核苷酸多态性(rs45458701)导致了阿特(a-)血型。平衡核苷转运体1(ENT1;也称为SLC29a1)最后一个细胞外环中的p.Glu391Lys变异已知不会改变其转运核苷和核苷类似物药物的能力。此外,我们鉴定出3名欧洲裔个体,他们的SLC29A1基因存在无效突变(c.589+1G>C)纯合子,因此具有奥古斯汀无效血型。这些缺乏ENT1的个体表现出关节周围和异位矿化,这证实了ENT1/SLC29A1在人类骨骼稳态中的重要作用,正如衰老的Slc29a1(-/-)小鼠的骨骼表型最近所提示的那样。我们的研究结果将奥古斯汀确立为一个新的血型系统,并将SLC29A1定位为以异位钙化/矿化为特征的特发性疾病的一个新候选基因。